Detail akcie Orion online

Business Summary: Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients, and the Diagnostics business segment develops, manufactures and markets diagnostic tests. The Company’s business comprises two main divisions: Proprietary Products and Specialty Products. Its Proprietary Products consist of patented prescription products in three therapy areas: central nervous system diseases, oncology and critical care, and Easyhaler pulmonary drugs. The Company’s Specialty Products, which include the provision of generic prescription drugs and self-care products for basic healthcare. In addition the Company also produces veterinary medicines for pets and production animals.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Orion Oyj revenues increased 21% to EUR771.1M. Net income applicable to common stockholders increased 50% to EUR143.9M. Revenues reflect Innovative Medicines segment increase of 78% to EUR244.5M, Branded Products segment increase of 11% to EUR157.4M, North America segment increase of 54% to EUR146.5M, Other Countries segment increase of 36% to EUR135M.